Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07451210 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction
A NA study of Physical Therapy and Ankle Reconstruction, sponsored by Texas Tech University Health Sciences Center.
- Recruiting
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 5
- Study locations
NCT07451210 is a NA study of Physical Therapy and Ankle Reconstruction that is actively recruiting participants, run by Texas Tech University Health Sciences Center. The registered enrollment target is 105 participants, below the 478-participant average among 8 other Physical Therapy trials with a reported enrollment target (78% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT07451210, a NA study of Physical Therapy and Ankle Reconstruction, is actively recruiting participants, sponsored by Texas Tech University Health Sciences Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this single blinded clinical trial is to investigate blood flow restriction (BFR) for rehabilitation of patients after ankle ligament reconstruction surgery. Outcome measures will be compared between the standard of care (SoC) and BFR groups at the end of the study intervention. Following standard surgical procedures, both groups will undergo physical therapy by a certified physical therapist for a minimum of 6 weeks. The SOC group will receive standard physical therapy without use of BFR. The BFR group will receive physical therapy with BFR. Outcome measures of interest will be taken at the start of physical therapy (time 0) and at the end of physical therapy (minimum of 6 weeks of PT) for both groups. Outcome measures of interest include: * muscle atrophy; * ankle function; * fatigability/manual muscle testing; * pain scores; * cardiovascular effects (heart rate, blood pressure).
Conditions Studied
Interventions
- DEVICE blood flow restriction
Study Locations (5)
Texas
- Physical Therapy Today (PTT) - Lubbock
- University Medical Center - Lubbock
- Northstar Surgery Center - Lubbock
- The Center for Orthopedic Surgery - Lubbock
- Texas Tech University Health Sciences Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07451210
The ClinicalTrials.gov registry entry for NCT07451210 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 478-participant average among 8 other Physical Therapy trials with a reported enrollment target (78% lower). The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Physical Therapy appearing as the primary indexed condition, and to 1 intervention - of which blood flow restriction is the first listed.
NCT07451210 reports 5 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07451210 about?
NCT07451210 is a clinical study titled "Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction". The goal of this single blinded clinical trial is to investigate blood flow restriction (BFR) for rehabilitation of patients after ankle ligament reconstruction surgery. Outcome measures will be compared between the standard of care (SoC) and BFR groups at the end of the study intervention. Followi...
What is the current status of trial NCT07451210?
This trial is currently recruiting. It is a NA study. The enrollment target is 105 participants. The study started on 2026-03-01. Estimated completion is 2027-12-31.
What conditions does trial NCT07451210 study?
This clinical trial studies the following conditions: Physical Therapy, Ankle Reconstruction, Blood Flow Restriction Therapy.
What interventions are being tested in trial NCT07451210?
The interventions under investigation include: blood flow restriction (DEVICE).
Who is sponsoring clinical trial NCT07451210?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07451210 being conducted?
This trial has 5 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Therapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Is Physical Therapy Clearance Before Arthroplasty Home Discharge Necessary?
RECRUITING · NA
-
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
RECRUITING · NA
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
-
Art and Physical Therapy in Pediatric HCT
ACTIVE NOT RECRUITING · NA
-
Functional Prehabilitation and Major Elective Surgery
COMPLETED · NA
-
Immersive Physical Therapy in the Neonatal Intensive Care Unit (NICU)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.